Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $4.9650 (5.64%) ($4.9650 - $4.9650) on Wed. Aug. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.19% (three month average) | RSI | 68 | Latest Price | $4.9650(5.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 9.5% a day on average for past five trading days. | Weekly Trend | ATRA advances 12.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XLU(69%) ACES(64%) ICLN(64%) LIT(56%) XLRE(55%) | Factors Impacting ATRA price | ATRA will decline at least -5.095% in a week (0% probabilities). XRT(7%) XOP(9%) EDOC(9%) TBT(-11%) UUP(-19%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -5.095% (StdDev 10.19%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.02(23.51%) | 10 Day Moving Average | $3.57(39.08%) | 20 Day Moving Average | $3.54(40.25%) | To recent high | -43.5% | To recent low | 73.9% | Market Cap | $369m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |